About KaryoLogic
KaryoLogic is a company based in Durham (United States) founded in 2008 was acquired by Clean Cells in April 2025. KaryoLogic offers products and services including Human Stem Cell Karyotyping and Digital PCR, Human Non-Stem Cell Karyotyping, Non-Human Species Karyotyping, and Fluorescence In Situ Hybridization. KaryoLogic operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Karyologic, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Clean Cells
(Apr 08, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KaryoLogic
KaryoLogic offers a comprehensive portfolio of products and services, including Human Stem Cell Karyotyping and Digital PCR, Human Non-Stem Cell Karyotyping, Non-Human Species Karyotyping, and Fluorescence In Situ Hybridization.
Analyzes chromosomes in human stem cells for research integrity
Performs chromosome analysis on human non-stem cells
Offers karyotyping for animal and other species
Detects specific DNA sequences in chromosomes
Funding Insights of KaryoLogic
Investors in KaryoLogic
KaryoLogic has secured backing from 1 investor. Prominent investors backing the company include Clean Cells.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers cell banking and virus banking services
|
Founded Year | Domain | Location |
Investments & Acquisitions by KaryoLogic
Financial Statements - KaryoLogic
Karyologic Comparisons
Competitors of KaryoLogic
KaryoLogic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Provider of laboratory tests for physicians
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| domain | founded_year | HQ Location |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
|
|
| domain | founded_year | HQ Location |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
Latest news on Karyologic
Frequently Asked Questions about KaryoLogic
KaryoLogic was founded in 2008.
KaryoLogic is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
KaryoLogic offers karyotyping services for human, mouse, and rare species, stem cell and cancer cell lines, as well as digital PCR services for human stem cells. They accept cell samples shipped from around the globe to their North Carolina USA location for high quality karyotyping services. KaryoLogic has also partnered with other biotech companies to improve their services.
KaryoLogic's top competitors include LabCorp, Charles River Laboratories and Cytel.
KaryoLogic offers Human Stem Cell Karyotyping and Digital PCR, Human Non-Stem Cell Karyotyping, Non-Human Species Karyotyping, and Fluorescence In Situ Hybridization.
KaryoLogic has 1 investor. Key investors include Clean Cells.